- ►diabetesjournals.org EA Ryan, JRT Lakey, BW Paty, S Imes, GS … - Diabetes, 2002 - Am Diabetes Assoc Clinical islet transplantation is gaining acceptance as a potential therapy,
particularly for subjects who have labile diabetes or problems with hypoglycemic
awareness. The risks of the procedure and long-term outcomes are still not ... Cited by 488 - Related articles - BL Direct - All 9 versions
NV Evgenov, Z Medarova, G Dai, S Bonner- … - Nature - carestream.ru Type 1 diabetes mellitus is characterized by the selective destruction of
insulin-producing beta cells, which leads to a deficiency in insulin secretion
and, as a result, to hyperglycemia. At present, transplantation of ... Cited by 84 - Related articles - BL Direct - All 14 versions
- ►nih.gov F Souza, N Simpson, A Raffo, C Saxena, A … - Journal of Clinical Investigation, 2006 - Am Soc Clin Investig 1 Department of Medicine and 2 Department of Radiology, Columbia University
Medical Center, New York, New York, USA. 3 Institute of Genetics and Biophysics
“Adriano Buzzati-Traverso,” Consiglio Nazionale delle Ricerche, Naples, ... Cited by 45 - Related articles - BL Direct - All 9 versions
AK Gupta, RR Naregalkar, VD Vaidya, M … - Nanomedicine, 2007 - Future Medicine Magnetic nanoparticles with appropriate surface coatings are increasingly being
used clinically for various biomedical applications, such as magnetic resonance
imaging, hyperthermia, drug delivery, tissue repair, cell and tissue ... Cited by 46 - Related articles - BL Direct - All 4 versions
BW Paty, S Bonner-Weir, MR Laughlin, AJ … - Transplantation, 2004 - journals.lww.com Background. Pancreatic islet transplantation can provide insulin independence
and near normal glu- cose control in selected patients with type 1 diabetes
mellitus. However, in most cases, achieving insulin independence ... Cited by 34 - Related articles - BL Direct - All 3 versions
IR Sweet, DL Cook, Å Lernmark, CJ … - Biochemical and Biophysical Research …, 2004 - Elsevier The β-cell loss seen in diabetes mellitus could be monitored clinically by
positron emission tomography (PET) if imaging agents were sufficiently specific
for β-cells to overcome the high ratio of non-β-cell to β-cell tissue in ... Cited by 32 - Related articles - All 4 versions
MO Larsen, B Rolin, M Wilken, RD Carr, CF … - Diabetes, 2003 - Am Diabetes Assoc Knowledge about β-cell mass and/or function could be of importance for the
early diagnosis and treatment of diabetes. However, measurement of β-cell
function as an estimate of β-cell mass is currently the only method ... Cited by 31 - Related articles - BL Direct - All 5 versions
NR Simpson, F Souza, P Witkowski, A Maffei, … - Nuclear medicine and biology, 2006 - Elsevier Type 1 diabetes (T1D) is a result of the autoimmune destruction of the
insulin-producing β cells of the islets of Langerhans—the endocrine component
of the pancreas [2]. This disease has an insipid beginning and may take ... Cited by 26 - Related articles - All 5 versions
- ►nih.gov SE Turvey, E Swart, MC Denis, U Mahmood, C … - Journal of Clinical Investigation, 2005 - Am Soc Clin Investig A major stumbling block for research on and treatment of type 1 diabetes is the
inability to directly, but noninvasively, visualize the lymphocytic/inflammatory
lesions in the pancreatic islets. One potential approach to surmounting ... Cited by 25 - Related articles - BL Direct - All 13 versions
